By activating a specific receptor it is possible to strengthen fragile bones and promote regeneration in an unprecedented way
A new study led by the University of Leipzig, Germany, in collaboration with Shandong University, China, has identified a cellular receptor called GPR133 that is essential for bone density. It works through bone-forming cells, known as osteoblasts, which are responsible for building and regenerating bone tissue, a process critical to maintaining bone health throughout life.
The discovery is relevant because osteoporosisone of the most common diseases in aging societies, it remains a major medical challenge. According to the declarationMillions of people, especially postmenopausal women, suffer bone loss and fractures that directly compromise their quality of life.
GPR133 and the potential for new treatments
The study, published in the journal Signal transduction and targeted therapyrevealed that the GPR133 receptor can be activated through chemical compounds, which paves the way for the development of new drug therapies with fewer side effects. Variations in GPR133 have previously been linked to bone density, which is why researchers focused their attention on the protein encoded by the gene.
…
See also
Osteoporosis: what it is, symptoms, treatment and whether it can be cured
Five bone-strengthening moves recommended by a fitness expert
This molecule hidden in coffee holds one of the keys to improving the aging of our muscles
Source: Terra
Ben Stock is a lifestyle journalist and author at Gossipify. He writes about topics such as health, wellness, travel, food and home decor. He provides practical advice and inspiration to improve well-being, keeps readers up to date with latest lifestyle news and trends, known for his engaging writing style, in-depth analysis and unique perspectives.
